Assembly Biosciences (ASMB) 10-K2017 FY Annual report

Filed: 8 Mar 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abbreviated, adapt, adulteration, advocated, Agreementwith, altered, APIC, biomarker, Bioscience, biosimilar, blank, block, bona, BPCIA, bribe, broader, broadly, burden, caution, check, Children, clarity, comment, commerce, concealing, congressional, Connecticut, constitutionality, contraindication, covertly, curtailment, custody, da, decelerate, defraud, deliverable, died, disagree, Easement, electrocardiography, Elizabeth, EMA, Enanta, Enterome, Europe, expedient, falsifying, family, fide, Finch, fraudulent, gap, Genome, Groton, heard, hepatocellular, HIPAA, IM, incremental, Inspector, interchangeable, interstate, Jr, judge, kickback, kind, Lacy, land, lifecyle, Mahony, mandate, meaningfully, mentioned, misbranding, misrepresentation, NASH, NOL, nonalcoholic, nondeductible, nonstatutory, Notably, Obama, opportunity, overtly, pathway, PCAOB, penalty, persuasive, physician, Portability, potency, Presidential, prioritizing, privacy, quantitative, qui, reclassification, referral, Relief, repatriated, repatriation, repeat, restraining, revenuefrom, rulemaking, SAB, scheme, serum, sooner, Specimen, stranded, subtitle, sunshine, Supreme, surface, Susan, ta, tam, Taxpayer, teaching, Thenew, topline, traditional, transmission, transparency, trick, Trump, unavailable, Vedanta, vendor, verification, VSOE, weigh, whistleblower, withheld

Removed: Adam, adjustment, administering, advisor, aerobic, afflict, anaerobic, Arnold, assigned, assigning, bacterium, Baraclude, calculated, cancer, clarifying, clothing, colon, combining, commensal, composition, concomitant, contrast, curve, deposit, diarrhea, die, donor, Dr, dry, EisnerAmper, elderly, Ellison, expiration, explore, expressing, extraction, failed, feasible, fidaxomicin, finalized, flora, flourish, focusing, gastro, GMP, growing, gut, hamper, head, hospital, industrial, intestinal, Lee, leverage, line, lining, lumen, lyophilize, lyophilized, metronidazole, mitigate, mouse, nosocomial, older, oncology, par, PhD, physical, postulated, precedent, predictable, premise, prescribed, problematic, purification, reclassifying, redundant, refractory, reliable, representing, resistance, restoring, retroactively, Russell, scalable, scintigraphy, screening, selecting, shift, simplified, suggested, survive, surviving, temperature, testable, transmitted, transplant, true, unchecked, validated, vancomycin, Veteran, Vice, virulence, Zlotnick

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ASMB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)

Registration Statement (Form S-8 No. 333-173613),

(2)

Registration Statement (Form S-8 No. 333-182167),

(3)

Registration Statement (Form S-8 No. 333-198803),

(4)

Registration Statement (Form S-3 No. 333-208806),

(5)

Registration Statement (Form S-8 No. 333-213019),

(6)

Registration Statement (Form S-8 No. 333-216902),

(7)

Registration Statement (Form S-8 No. 333-219919),

(8)

Registration Statement (Form S-3 No. 333-222366),

of our reports dated March 7, 2018, with respect to the consolidated financial statements of Assembly Biosciences, Inc. and Subsidiaries and the effectiveness of internal control over financial reporting of Assembly Biosciences, Inc. and Subsidiaries included in this Annual Report (Form 10-K) of Assembly Biosciences, Inc. and Subsidiaries for the year ended December 31, 2017.

/s/ Ernst & Young LLP

Stamford, Connecticut

March 7, 2018